Foghorn Therapeutics to Participate in the 41st Cowen Annual Healthcare Conference
Share: CAMBRIDGE, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (NASDAQ:FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, today announced that Sam Agresta, M.D., M.P.H, Chief Medical officer is scheduled to participate in a Leukemias panel discussion at the Cowen 41 st Annual Healthcare Conference at 11:40 a.m. ET on March 3, 2021. About Foghorn Therapeutics Foghorn ® Therapeutics is discovering and developing a novel class of medicines targeting ge...
Source: benzinga.com